From Frequency Nabs $32M, Will Push Hearing-Loss Drugs To Human Studies:

Cochlear hair cells
Cochlear hair cells

Cochlear hair cells, photo courtesy of Will McLean, VP Biology and Regenerative Medicine at Frequency Therapeutics.